Venture Capital and Private Equity Principals · Shanghai
The AZ-CICC Healthcare Investment Fund is jointly established by AstraZeneca and CICC (China International Capital Corporation) Capital that focuses on the investment in healthcare industry. It is a first-of-its-kind collaboration between a global pharmaceutical company and a leading Chinese investment firm. The fund is committed to bringing together global high-quality healthcare and financial resources to support the growth of its portfolio companies and empower the investment partners. The fund identifies investment from early to the mid-to-late stage across 4 strategic categories, including Medicine and Biotechnology, Medical Devices, Diagnostic Techniques as well as Digital Health and Services. The investment team have highly diversed educational backgrounds across biopharmaceutical and finance, as well as years of experience in drug development, strategic consulting in the medical industry and capital operations. 阿斯利康中金医疗产业基金是由阿斯利康与中金资本联合发起，专注于医疗健康产业投资的私募基金。融合阿斯利康全球的产业优势以及中金资本丰富的资本运作经验，基金聚焦于生物医药、医疗器械、诊断服务、数字医疗等投资领域，致力于汇聚产融资源，为企业及投资伙伴提供从研发到商业化的双向赋能，共同助力中国医疗健康产业创新发展。 BP Submission: [email protected]